© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
April 09, 2015
Patients with relapsing-remitting multiple sclerosis (RRMS) who received a non-myeloablative hematopoietic stem cell transplant (HSCT) experienced improved measures of disability and quality of life.
July 01, 2014
Stephen Vogt, PharmD, Chief Executive Officer and President of BioPlus Specialty Pharmacy, discusses the ongoing debate surrounding the high price of Hepatitis C treatments versus the efficacy of the drug.
June 30, 2014
Biologic agent golimumab effective over 5-year span in treating disease symptoms and improving quality of life.
June 26, 2014
Cardiovascular risk related to severity of inflammation, but not associated with disease duration